Eunpi Cho , Joshua Schiffer , Kathleen Murphy , B. Douglas Smith
{"title":"Isolated Granulocytic Sarcoma: Case Reports of Three Rare Presentations and Review","authors":"Eunpi Cho , Joshua Schiffer , Kathleen Murphy , B. Douglas Smith","doi":"10.3816/CLK.2008.n.039","DOIUrl":null,"url":null,"abstract":"<div><p>Granulocytic sarcomas are rare, extramedullary tumors composed of immature myeloid cells. Traditionally, these tumors present in patients with known leukemias; however, granulocytic sarcomas may present as an isolated finding in patients without known disease. As such, isolated granulocytic sarcomas may present a diagnostic challenge for clinicians taking care of the patient. Moreover, these tumors also create a therapeutic challenge for clinicians as they generally carry a poor prognosis and often have short-lived responses to systemic therapy with cytarabine-based chemotherapy. An improved understanding of the biology of granulocytic sarcomas may reveal targets accessible to some of the new biologically active agents being studied across oncology. This report of 3 usual presentations of granulocytic sarcomas and a brief review of the known pathophysiology reminds us that there is much work to do to improve outcomes for our patients.</p></div>","PeriodicalId":100271,"journal":{"name":"Clinical Leukemia","volume":"2 4","pages":"Pages 275-279"},"PeriodicalIF":0.0000,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3816/CLK.2008.n.039","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1931692513600455","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Granulocytic sarcomas are rare, extramedullary tumors composed of immature myeloid cells. Traditionally, these tumors present in patients with known leukemias; however, granulocytic sarcomas may present as an isolated finding in patients without known disease. As such, isolated granulocytic sarcomas may present a diagnostic challenge for clinicians taking care of the patient. Moreover, these tumors also create a therapeutic challenge for clinicians as they generally carry a poor prognosis and often have short-lived responses to systemic therapy with cytarabine-based chemotherapy. An improved understanding of the biology of granulocytic sarcomas may reveal targets accessible to some of the new biologically active agents being studied across oncology. This report of 3 usual presentations of granulocytic sarcomas and a brief review of the known pathophysiology reminds us that there is much work to do to improve outcomes for our patients.